Novel Agents and Combinations in Hodgkin Lymphoma
0 Pogledi
• 07/09/23
0
0
Ugraditi
administrator
Pretplatnici
Panelists discuss novel agents, such as HDAC inhibitors, being explored in clinical trials for patients with Hodgkin lymphoma.
For more from this discussion, visit http://www.onclive.com/peer-exchange/lymphoma
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari